Vancouver, British Columbia–(Newsfile Corp. – November 21, 2025) – Arya Resources Ltd. (TSXV: RBZ) (“Arya” or the “Company”) is pleased to announce that, subject to regulatory approval, it has engaged Independent Trading Group (“ITG”) to provide market-making services in accordance with the policies of the TSX Venture Exchange. ITG will …
Read More »HAW Capital 2 Corp. Enters into Merger Agreement for Qualifying Transaction with Naked Revival Inc.
Calgary, Alberta–(Newsfile Corp. – November 21, 2025) – HAW Capital 2 Corp. (TSXV: HAW.P) (“HAW 2“), a capital pool company under TSX Venture Exchange (the “TSXV“) Policy 2.4 (the “CPC Policy“), is pleased to announce that it has entered into a merger agreement dated November 21, 2025 (the “Merger Agreement“), with a …
Read More »Corton Capital Inc. Announces November 2025 Distributions for the Exchange Traded Fund
Toronto, Ontario–(Newsfile Corp. – November 21, 2025) – Corton Capital Inc. (“Corton”) today announces cash distributions for the Class ETF Units of the Corton Enhanced Income Fund for the month of November. The cash distributions will be paid on or about December 5, 2025 to unitholders of record on November …
Read More »Amex Announces Grant of Stock Options and Restricted Share Units
Montreal, Quebec–(Newsfile Corp. – November 21, 2025) – Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) (“Amex” or the “Company“) announces a grant of 3,250,000 incentive stock options (the “Options“) and 2,026,000 restricted share units (the “RSUs“) to certain directors, officers, employees, and consultants to the Company. Each Option is exercisable …
Read More »Azincourt Energy Corp. Closes Private Placement
Vancouver, British Columbia–(Newsfile Corp. – November 21, 2025) – AZINCOURT ENERGY CORP. (TSXV: AAZ) (“Azincourt” or the “Company”) is pleased to announce it has closed its non-brokered private placement of 40,000,000 flow through units (the “FT Units”) offered at a price of C$0.025 per FT Unit for gross proceeds of C$1,000,000 (the “Offering”). …
Read More »CSE Bulletin: New Listing – CAT Strategic Metals Corporation 21NOV2030 Warrants
Toronto, Ontario–(Newsfile Corp. – Le 21 novembre/November 2025) – Further to bulletins 2025-1035 and 2025-1136 describing the Rights Offering, CAT Strategic Metals Corporation 21NOV2030 Warrants have been approved for listing. Each Warrant shall entitle each warrantholder thereof, upon exercise at any time after the Issue Date and prior to the …
Read More »Spark Energy Minerals Announces Non-Brokered Private Placement to Fund Near-Term Drilling at Arapaima
Vancouver, British Columbia–(Newsfile Corp. – November 21, 2025) – Spark Energy Minerals Inc. (CSE: SPRK) (OTCID: SPARF) (FSE: 8PC) (“Spark” or the “Company”) is pleased to announce it intends to complete a non-brokered private placement of up to of up to $500,000 by offering up to 10,000,000 units of the Company …
Read More »Galleon Gold Announces Issuance of Shares for Interest Payment on Convertible Debentures
Toronto, Ontario–(Newsfile Corp. – November 21, 2025) – Galleon Gold Corp. (TSXV: GGO) (FSE: 3H90) (the “Company” or “Galleon Gold“) announces that further to its news release of November 17, 2025, under the terms of the convertible debentures (the “Convertible Debentures”) issued on April 12, 2024, April 19, 2024 and …
Read More »Alico to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Fort Myers, Florida–(Newsfile Corp. – November 21, 2025) – Alico, Inc. (NASDAQ: ALCO) (“Alico” or the “Company”) today announced that John Kiernan, the Company’s President and Chief Executive Officer, will present and host one-on-one meetings with investors at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference, taking place …
Read More »Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) 3Q25
Dallas, Texas–(Newsfile Corp. – November 21, 2025) – OS Therapies Inc. (NYSE American: OSTX): Stonegate Capital Partners updates their coverage on OS Therapies Inc. (NYSE American: OSTX). OS Therapies advanced key clinical, regulatory, and commercial milestones in 3Q25 as it moves closer to bringing OST-HER2 to patients with recurrent, fully …
Read More »
Matribhumi Samachar English